Mirae Asset Global Investments Co. Ltd. cut its holdings in Myriad Genetics, Inc. (NASDAQ: MYGN – Get Rating) stock by 18.6% in the fourth quarter, according to the company in its most recent disclosure to the Securities and Exchange Commission (SEC). The institutional investor owned 325,422 shares of the company after selling 74,151 shares during…
Tara Rothenhoefer started taking tyrzepatide as part of a weight loss clinical trial and lost 176 pounds on the drug. She now worries about losing access to the drug when a coupon expires in June.Courtesy of Tara Rothenhoefer Tirzepatide has the potential to be a new weight-loss treatment, but it could be costly for patients….
Tara Rothenhoefer started taking tyrzepatide as part of a weight loss clinical trial and lost 176 pounds on the drug. She now worries about losing access to the drug when a coupon expires in June. Courtesy of Tara Rothenhoefer Tirzepatide has the potential to be a new weight-loss treatment, but it could be costly for…
The researchers have important implications for the ongoing fight against malaria, a disease that affects an estimated 247 million people and causes more than 619,000 deaths each year, predominantly among young children. It was long believed that the evolution of malaria parasites to resist an important antimalarial drug was associated exclusively with a specific gene….